French bill's approval means more sales taxes and price cuts for pharma in 2012
This article was originally published in SRA
Executive Summary
A higher levy on pharmaceutical sales, more price cuts and greater use of medico-economic assessments are all in store next year after the lower house of the French parliament finally adopted the social security financing bill for 20121.